Centerra Gold slips after earnings as valuation discount deepens

Centerra Gold has dropped a further 7% on the week to CAD 27.45, extending a 10% one-month decline, and the post-earnings selling has pushed the stock to its cheapest valuation levels in months without yet attracting a meaningful change in analyst or short-side conviction.

The stock reported on October 29 and fell 4.7% the following session. That reaction was squarely in line with the cautious setup described ahead of the print: no short-side squeeze pressure, no options positioning of note, and a valuation already priced for disappointment. The question now is whether the post-results selloff has created a fresh entry point or simply confirmed the market's existing scepticism. The trailing P/E has compressed to around 10.1x and EV/EBITDA has slipped to 4.7x, both lower than a week ago. Earnings yield ranks in the 89th percentile of the ORTEX universe and EV/EBIT in the 93rd. At these multiples Centerra screens as one of the cheaper gold producers on the TSX, though cheap has been the story for most of 2026 without a re-rating catalyst to match.

The lending market tells a story of complete indifference from short sellers. Short interest is unchanged on the week at 1.95% of the free float, a level that has barely moved in a month. Borrowing costs have ticked up 35% over the past week to 0.78%, but that follows a period of sharp declines and remains negligible in absolute terms. Availability is extraordinarily loose at 2,816% of short interest, meaning there are roughly 28 shares available to borrow for every one already lent out. The borrow market is not signalling any new conviction from the short side after the earnings miss.

Peer context does little to separate Centerra from a sector-wide pullback. Close correlates KNT and WPM are each down 6% to 7% on the week, ELD and IMG off 7% to 8%, and AEM down 7.4%. The selling appears broad rather than stock-specific, though Centerra's 7% weekly decline lands roughly in the middle of the peer group. The underperformance versus EQX, which fell only 4%, is worth monitoring given that both trade at comparable valuations.

Institutional ownership gives some ballast to the value case. L1 Capital holds 8.4% of shares after adding more than nine million shares as of June 30. Donald Smith, a deep-value manager, holds 7.98% with only a minor trim in the latest reported period. Van Eck Associates, whose gold ETF holdings make it a natural barometer of sector sentiment, holds 6.9% and was marginally adding as of September. All three are patient, fundamentals-driven holders rather than momentum players, and their combined position of well over 20% of shares outstanding limits the free float available to sellers. No 13D activist is on the register, and the Schedule 13G holders listed are passive under ORTEX's disclosure framework, though stakes are as-last-disclosed around the 5% threshold and positions can change without a further filing.

The next earnings event is not until February 19, 2027, leaving the stock to trade on sector flows and gold price direction for the next three months. The key questions heading into that print are whether the operational issues flagged in the October results have stabilised, and whether gold's recent weakness reverses enough to lift sector-wide sentiment before Centerra's discounted multiple becomes a catalyst in itself.